Tuesday, November 21, 2017 8:12:08 AM
So in that vein, $40 mil USD into 274 mil shares is .14. Without any multiple and IF the feed-in tariff revenue is mostly profit. I guess it might be mostly profit since Falak has been bankrolling the operating costs and they own most of the shares anyway. The $1.5 mil or whatever in current liabilities can be wiped out quick, plus paying down the financing costs. The Q did mentioned equity and debt financing which is why I was using fully diluted shares just to be conservative.
So even with a super low multiple of 3, my opinion would be the .40 range share price as a base. Take a bigger multiple and it starts getting weird! :)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM